You just read:

Aragon Pharmaceuticals Raises $50 Million in Series D Financing to Advance Promising Therapeutic Candidates for Hormone-Driven Cancers

News provided by

Aragon Pharmaceuticals

Oct 04, 2012, 08:00 ET